neurology

News
Amylyx_logo

Amylyx bags first approval for ALS drug Albrioza

Amylyx Pharmaceuticals' efforts to bring its amyotrophic lateral sclerosis therapy AMX0035 to market in the US have run into some roadblocks, so an approval by Health Canada is a welcome re

News
Biogen Hillerød, Denmark

Biogen bolsters pipeline again with Alectos deal

Biogen has added a preclinical-stage drug candidate for Parkinson's disease via a $722.5 million licensing agreement with Alectos Therapeutic, as it continues to rebuild a pipeline behind its si